Use access key #2 to skip to page content.
$15.02 -0.25 (-1.64%)
5/16/2008 4:00 PM

Omrix Biopharmaceuticals, Inc. (OMRI)

CAPS Rating:
****

A commercial-stage biopharmaceutical company that develops and markets innovative biological products.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other players to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating OMRI

Add Stock to Watchlist

What the Community Thinks Add a widget featuring this stock to your blog!

Total Players

373 Outperforms
22 Underperforms
 

All-Stars

102 Outperforms
4 Underperforms
 

Wall Street

6 Outperforms
0 Underperforms
 

Players bullish on OMRI are also bullish on:

Players bearish on OMRI are also bearish on:

Ticker Tags

Biotechnology (291), Micro Cap (4824)
Suggest a tag

Omrix Biopharmaceuticals, Inc. At A Glance

Current Price: $15.02
Last Trade Time: 5/16/2008 4:00 PM
Open: $15.36
Previous Close: $15.27
Daily Range: $14.97 - $15.55
52-Week Range: $11.81 - $39.07
Volume: 135,563
Market Cap: $261.38M
P/E Ratio: 24.24
Compare Our Special Broker Offers!

Stock Trends

OMRI VS S&P 500 (SPY)

OMRI 12 month chart vs. S&P

News & Discussion Boards

Sorry no news articles available for OMRI.

Top Bull Pitch

Recs

1

Omrix Biopharmaceuticals, Inc. (OMRI)

Avatar tiobueno (21.95) Submitted: 4/04/08 12:25 PM

March 20, 2008 4:57 PM EDT

Omrix Biopharmaceuticals, Inc. (Nasdaq: OMRI) CEO, Robert Taub, bought 80,000 shares from 03/19-03/20 at prices from $12.10-$12.31, bringing his stake to 2,797,103 shares.

Shares of Omrix Biopharmaceuticals are trading near 52-week lows and is down 65% year to date.

Omr...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

Omrix Biopharmaceuticals, Inc. (OMRI)

Avatar KenN513 (98.88) Submitted: 7/16/07 11:31 AM

PEG is 3+. Other indicators are good, but the market has valued them.

Replies: 0 | Reply | Permalink

CAPS Players

picks per page. CHANGE

Results 1 - 5 of 61 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (OMRI)

Avatar ResearchLover (98.29) Submitted: 5/15/08 2:36 PM : Outperform Start Price: $15.33 OMRI Score: -2.68

Looks like analysts give it a price target in the 20s, and growth projections are up, though fluctuating. Profit margin looks good. I actually have owned competitor KG since december 2007, but that is a defensive position, whereas this is one with somewhat risky growth prospects.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (OMRI)

Avatar richardrogers4 (61.29) Submitted: 5/14/08 5:00 PM : Outperform Start Price: $15.16 OMRI Score: -1.97

RB Pick

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (OMRI)

Avatar DavidBear (< 20) Submitted: 5/14/08 9:25 AM : Outperform Start Price: $14.40 OMRI Score: 3.13

Insider buying, depressed price, PEG of 0.7.
What is not to like?

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (OMRI)

Avatar TMFSarahGen (99.83) Submitted: 5/13/08 5:06 PM : Outperform Start Price: $13.53 OMRI Score: 8.16

a biotech with a 20 p/e or lower? a biotech that makes money? AND insider buying?!! Sign me up! That's OMRI.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (OMRI)

Avatar YoungInvestor99 (75.52) Submitted: 5/06/08 8:07 PM : Outperform Start Price: $14.70 OMRI Score: 1.68

RuleBreaker Pick

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 61 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 6 of 6  

picks per page. CHANGE

Top
Pick
Player NamePlayer RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackRodmanRen < 20 09/11/07 Outperform NS $33.70-55.43%-2.45%-52.98
TrackCowenandCo 65.27 06/29/07 Outperform NS $29.88-49.73%-5.46%-44.27
TrackCitigroup 89.10 02/02/07 Outperform NS $35.40-57.57%-1.43%-56.14
TrackUBS 93.41 01/05/07 Outperform NS $31.88-52.89%+1.29%-54.18
TrackBreanMurray 88.12 11/20/06 Outperform NS $29.75-49.51%+1.72%-51.23
TrackLeerinkSwan 43.89 11/08/06 Outperform NS $23.14-35.09%+3.56%-38.65

Results 1 - 6 of 6  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners